Use of Multiphoton Microscopy in the Diagnosis of Cancer

Completed · Phase 1

Conditions studied: Bladder Cancer, Prostate Cancer

In brief

Multiphoton microscopy (MPM) has been shown to be able to image tissue at a cellular level. Our project will initially evaluated the ability of MPM imaging to distinguish normal bladder urothelium from atypical and malignant urothelium in the ex vivo setting. After development of sufficient criteria, we plan to develop an endoscopic bladder probe that will provide a non-invasive means to image the interior of the bladder at the cellular level, which would provide direct evidence of the presence of tumor without a biopsy. After exhibiting usefulness of MPM imaging for bladder cancer, we will look at other organs beginning with the colon.

Key facts

Study ID

NCT00652210

Run by

Weill Medical College of Cornell University

People needed

344

Starts

2005-06-01

Expected to finish

2015-09-01

Last updated by the study team

2015-12-10

Who can join

Age: 21 and older, up to 85. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Anyone who presents with bladder and/or prostate cancer

Where it is running

• Weill Cornell Medical College — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.